Stockreport

Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week

Panbela Therapeutics, Inc.  (PBLA) 
PDF MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics [Read more]